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Ewing’s sarcoma (ES) is the second 
most common pediatric bone cancer. 
With patients having a 5-year survival 
rate of 30%, alternative treatments 
must be developed. Certain 
cannabinoids have been shown to 
induce apoptosis and inhibit 
angiogenesis in ES cells/tumors. We 
are specifically observing naturally 
occurring cannabidiol (CBD) and 
ajulemic acid (AJA), a synthetic 
cannabinoid. AJA is structurally similar 
to tetrahydrocannabinol (THC), the 
active compound in marijuana. 
However, AJA and CBD do not produce 
any psychoactive effects, making them 
viable treatments for children.  
 
Abstract 
Measuring Tumor Interstitial Fluid Pressure in vivo: 
monitoring TIFP in mouse xenograft ES tumors over 30mins. 
after administration of AJA and CBD (0.025mg/g) 
Change in TIFP over 
30mins. 
Control +7% 
AJA* -27% 
CBD* -41% 
Angiogenic Array: quantifying the effect of AJA on 55 various 
angiogenic proteins via antibody binding and chemiluminescence 
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- Synergistic administration of cannabinoids and chemotherapy drugs 
- Investigating cannabinoids’ effects on angiogenic protein receptors 
- Replicate spheroid invasion assay with ES cells 
To elucidate the mechanism by which AJA affects Ewing’s Sarcoma 
cellular pathways, we conducted an angiogenic array to observe AJA’s 
effects on fifty-five different angiogenic proteins. The angiogenic array 
showed potential upregulation of TIMP-1, an angiogenic inhibitor, but 
similar results have yet to be replicated in subsequent ELISA’s. 
 Solid tumors commonly have high vascular densities and increased 
interstitial fluid pressures (IFP), which reduce the efficacy of treatments 
by inhibiting the absorption of therapeutic drugs. To determine the 
effects of AJA and CBD on IFP, and thus on vasculature in vivo, we 
measured IFP levels in mouse xenograft ES tumors. AJA and CBD both 
produced significant decreases in IFP within thirty minutes of injection, 
affirming their potential as legitimate cancer treatments. 
 
Results/Conclusion: TIMP-1, a matrix metalloproteinase 
inhibitor, was dramatically up-regulated upon treatment with 
AJA. TIMP-1 inhibits ECM degradation, making it anti-angiogenic.  
Fig. 4 - 1mm cross-sections of mouse aortas plated in matrigel, treated with indicated concentrations of AJA. 
Fig. 8 – Angiogenic Array membrane luminescing 
Δ-9 THC 
Fig. 3 – Cannabinoid structures 
Fig. 1 – Common ES tumor locations 
AJA CBD 
Table 1 – Change in TIFP over 30mins. 
*p-value < 0.05 
 
Fig. 10 – measuring TIFP in mouse 
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Background 
Previous Experiments Experiments (Cont.) 
Fig. 2 – ES tumor in femur 
Aortic Ring Assays showed cannabinoids’ ability to suppress 
angiogenesis. However, subsequent ELISA’s show cannabinoids 
produce no consistent effects on common angiogenic proteins. 
Experiments & Results 
Results/Conclusion: Mice treated with AJA and CBD displayed 
remarkable decreases in TIFP. 
Future Studies 
TIMP-1 ELISA’s: quantifying effect of AJA on TIMP-1 in vitro 
Fig. 5-7 – ELISA’s for VEGF, TGF-β1, and thrombospondin1 
Results/Conclusion: AJA had no consistent effect on TIMP-1 
Control 
AJA 5μM 
Fig. 11 – Spheroid invasion assays 
Fig. 9 – supernatant TIMP-1 levels upon AJA treatment 
Unt. 10μM AJA 20μM AJA 32μM AJA 
